Acting urgently to grow our impact
In 2019, Evidence Action set a five-year organizational strategy with an ambitious goal to double our impact by 2024. We have been hard at work since and - despite the…
In 2019, Evidence Action set a five-year organizational strategy with an ambitious goal to double our impact by 2024. We have been hard at work since and - despite the…
Parasitic worms, or soil-transmitted helminths (STH), are among the most prevalent causes of illness among the world’s poorest and most vulnerable populations, especially children. Close to a quarter of the world’s population is infected with at least one species of STH, and globally an estimated 870 million children are at risk of a new infection
Regular mass deworming of children once or twice a year has greatly contributed to the reductionin the prevalence of worms in several countries. National, school-based deworming programs are the most efficient and cost-effective way to reach kids, and are a cornerstone of addressing the public health threat of STH and schistosomiasis in a growing number of countries.
But there is a growing recognition that treatment of children alone might not be sufficient to break the transmission of worm infections. Infected adults constitute a latent reservoir of worm eggs and present a significant re-infection risk to children, in particular for hookworm, one of the three STH. So, how do we reduce the reinfection of children by treating adults? Enter Take Up, a new research project of Evidence Action's Deworm the World Initiative.